Abstract: Isocitrate dehydrogenase 1/2 (IDH1/2) mutations are often detected in lower-grade gliomas (LGG) and result into 2-hydroxyglutarate (2HG) synthesis. Prior studies showed that 2HG can be detected in vivo using magnetic resonance spectroscopy (MRS), but its accuracy and translational impact are still under investigation. Purpose: To investigate the clinical feasibility of MRS for in vivo detection and quantification of 2HG on consecutive treatment-naïve suspect LGG patients and to compare MRS accuracy with tissue IDH1/2 analysis. Methods: MRS spectra at 3 T were acquired with 1H-MRS single-voxel PRESS 2HG-tailored sequences with TE 30 (group 1) or TE 97 (groups 2A and B). Voxel sizes were 1.5 × 1.5 × 1.5 cm3 for group 1 (n = 13) and group 2A (n = 14) and 2 × 2 × 2 cm3 for group 2B (n = 32). Multiple metabolites’ concentrations were analyzed with LCModel. Tumors were assessed for IDH status and main molecular markers. 2HG levels in urine/blood were measured by liquid chromatography–mass spectrometry. Results: The larger voxel TE 97 sequence resulted in highest specificity (100%), sensitivity (79%), and accuracy (87%). Urine and blood 2HG did not result predictive. Conclusion: Our data confirm that 2 × 2 × 2-cm3 voxel TE 97 MRS shows high accuracy for 2HG detection, with good sensitivity and 100% specificity in distinguishing IDH mutant gliomas. Main limits of the technique are small tumor volume and low cellularity. Integrating 2HG-MRS with other metabolites may help non-invasive diagnosis of glioma, prognostic assessment, and treatment planning in clinical setting.
In vivo 2-hydroxyglutarate-proton magnetic resonance spectroscopy (3 T, PRESS technique) in treatment-naïve suspect lower-grade gliomas: feasibility and accuracy in a clinical setting / V. Cuccarini, L. Antelmi, B. Pollo, R. Paterra, C. Calatozzolo, A. Nigri, F. DiMeco, M. Eoli, G. Finocchiaro, G. Brenna, I. Tramacere, M.G. Bruzzone, E. Anghileri. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-1874. - 41:2(2020), pp. 347-355.
|Titolo:||In vivo 2-hydroxyglutarate-proton magnetic resonance spectroscopy (3 T, PRESS technique) in treatment-naïve suspect lower-grade gliomas: feasibility and accuracy in a clinical setting|
CUCCARINI, VALERIA (Primo)
|Parole Chiave:||2-hydroxyglutarate (2HG); Glioma; Isocitrate dehydrogenase (IDH); Magnetic resonance spectroscopy (MRS); Point-resolved spectroscopy (PRESS)|
|Settore Scientifico Disciplinare:||Settore MED/27 - Neurochirurgia|
|Data di pubblicazione:||2020|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1007/s10072-019-04087-9|
|Appare nelle tipologie:||01 - Articolo su periodico|
File in questo prodotto:
|In vivo 2-hydroxyglutarate-proton magnetic resonance spectroscopy .pdf||Publisher's version/PDF||Administrator Richiedi una copia|